-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Amgen, Raises Price Target to $470

Benzinga·10/09/2026 15:31:02
UBS analyst Michael Yee maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $430 to $470.